Paliperidone Palmitate Long-Acting Injectable Given Intramuscularly in the Deltoid Versus the Gluteal Muscle Are They Therapeutically Equivalent?

被引：6
|
作者：
Ravenstijn, Paulien [1 ]
Samtani, Mahesh [2 ]
Russu, Alberto [1 ]
Hough, David [3 ]
Gopal, Srihari [3 ]
机构：
[1] Janssen Res & Dev LLC, Beerse, Belgium
[2] Janssen Res & Dev LLC, Raritan, NJ USA
[3] Janssen Res & Dev LLC, Titusville, NJ USA
来源：
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 2016年 / 36卷 / 06期
关键词：
SCHIZOPHRENIA; INJECTIONS;
D O I：
10.1097/JCP.0000000000000610
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：744 / 745
页数：2
相关论文
共 50 条
  • [21] Acceptance of the Deltoid Muscle Injection of Aripiprazole Long-acting Injectable in the Patients with Schizophrenia
    Kamei, Hiroyuki
    Homma, Yuki
    Takeuchi, Ippei
    Hajitsu, Genta
    Tozawa, Kaori
    Hatano, Masakazu
    Fukui, Aiko
    Hanya, Manako
    Yamada, Shigeki
    Iwata, Nakao
    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2020, 18 (01) : 49 - 57
  • [22] Onset and persistence of efficacy by symptom domain with long-acting injectable paliperidone palmitate in patients with schizophrenia
    Alphs, Larry
    Bossie, Cynthia A.
    Fu, Dong-Jing
    Ma, Yi-Wen
    Sliwa, Jennifer Kern
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (07) : 1029 - 1042
  • [23] Factors Associated with the Initiation of Long-Acting Injectable Paliperidone Palmitate Versus Aripiprazole Among Medicaid Patients with Schizophrenia: An Observational Study
    Cai, Qian
    Patel, Charmi
    Kim, Edward
    Connolly, Nancy
    Tunceli, Ozgur
    El Khoury, Antoine C.
    ADVANCES IN THERAPY, 2019, 36 (04) : 858 - 869
  • [24] Factors Associated with the Initiation of Long-Acting Injectable Paliperidone Palmitate Versus Aripiprazole Among Medicaid Patients with Schizophrenia: An Observational Study
    Qian Cai
    Charmi Patel
    Edward Kim
    Nancy Connolly
    Ozgur Tunceli
    Antoine C. El Khoury
    Advances in Therapy, 2019, 36 : 858 - 869
  • [25] Comparison between long-acting injectable aripiprazole versus paliperidone palmitate in the treatment of schizophrenia: systematic review and indirect treatment comparison
    Pae, Chi-Un
    Wang, Sheng-Min
    Han, Changsu
    Bahk, Won-Myong
    Lee, Soo-Jung
    Patkar, Ashwin A.
    Masand, Prakash S.
    Serretti, Alessandro
    Emsley, Robin
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2017, 32 (05) : 235 - 248
  • [26] Onset of Efficacy of Long-acting Injectable Paliperidone Palmitate for Negative Symptoms and Anxiety/Depression in Subjects With Schizophrenia
    Fu, Dong-Jing
    Bossie, Cynthia A.
    Sliwa, Jennifer Kern
    Ma, Yi-Wen
    Alphs, Larry
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S511 - S512
  • [27] Cost-Minimisation Analysis of Paliperidone Palmitate Long-Acting Treatment versus Risperidone Long-Acting Treatment for Schizophrenia in Spain
    Javier Quintero
    Itziar Oyagüez
    Beatriz González
    Ignacio Cuervo-Arango
    Ignacio García
    Miguel Angel Casado
    Clinical Drug Investigation, 2016, 36 : 479 - 490
  • [28] Paliperidone palmitate and risperidone long-acting injectable in subjects with schizophrenia recently treated with oral risperidone or other oral antipsychotics
    Alphs, Larry
    Bossie, Cynthia A.
    Sliwa, Jennifer Kern
    Fu, Dong-Jing
    Ma, Yi-Wen
    Hulihan, Joseph
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2013, 9 : 341 - 350
  • [29] Evaluation of paliperidone palmitate long-acting injectable antipsychotic therapy as an early treatment option in patients with schizophrenia
    Brown, Brianne
    Turkoz, Ibrahim
    Mancevski, Branislav
    Mathews, Maju
    EARLY INTERVENTION IN PSYCHIATRY, 2020, 14 (04) : 428 - 438
  • [30] Effectiveness of long-acting paliperidone palmitate in borderline personality disorder
    Palomares, Nerea
    Montes, Ana
    Diaz-Marsa, Marina
    Carrasco, Jose L.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2015, 30 (06) : 338 - 341
12345